1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Doxorubicin Market – By Drug Formulation

1.3.2        North America Doxorubicin Market – By Application

1.3.3        North America Doxorubicin Market – By Distribution Channel

1.3.4        North America Doxorubicin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Doxorubicin Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Doxorubicin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Increasing Preference for Chemotherapy

5.2         Market Restraints

5.2.1        Potential Side-effects Associated with Doxorubicin

5.3         Market Opportunities

5.3.1        Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention

5.4         Future Trends

5.4.1        Increasing Approval of Generic Products

5.5         Impact Analysis

6.           Doxorubicin Market– North America Analysis

6.1         North America Doxorubicin Market Revenue Forecast and Analysis

7.           North America Doxorubicin Market Analysis – By Drug Formulation

7.1         Overview

7.2         North America Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)

7.3         Lyophilized Powder

7.3.1        Overview

7.3.2        Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

7.4         Doxorubicin Injection

7.4.1        Overview

7.4.2        Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.           North America Doxorubicin Market Analysis – By Application

8.1         Overview

8.2         North America Doxorubicin Market Share, By Application 2022 & 2028 (%)

8.3         Breast Cancer

8.3.1        Overview

8.3.2        Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.4         Kidney Cancer

8.4.1        Overview

8.4.2        Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.5         Liver Cancer

8.5.1        Overview

8.5.2        Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.6         Sarcoma

8.6.1        Overview

8.6.2        Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.7         Ovarian Cancer

8.7.1        Overview

8.7.2        Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.8         Lung Cancer

8.8.1        Overview

8.8.2        Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.9         Leukemia

8.9.1        Overview

8.9.2        Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.10      Multiple Myeloma

8.10.1     Overview

8.10.2     Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.11      Others

8.11.1     Overview

8.11.2     Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.           North America Doxorubicin Market Analysis – By Disribution Channel

9.1         Overview

9.2         North America Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

10.        North America Doxorubicin Market Analysis – By Country

10.1      Overview

10.1.1     North America: Doxorubicin Market, by Country, 2022 & 2028 (%)

10.1.1.1       US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       US: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.1.4       US: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5       US: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.1.2       Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Canada: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.2.4       Canada: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5       Canada: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.1.3       Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Mexico: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.3.4       Mexico: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5       Mexico: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Accord Healthcare

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Cipla Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Meiji Holdings Co., Ltd.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Novartis AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Pfizer Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Sun Pharmaceutical Industries Ltd

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Baxter International Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Zydus Cadila

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             US Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done By Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Doxorubicin Market Segmentation

Figure 2.           North America Doxorubicin Market Segmentation, By Country

Figure 3.           North America Doxorubicin Market Overview

Figure 4.           North America Doxorubicin Market, By Drug Formulation

Figure 5.           North America Doxorubicin Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           North America Doxorubicin Market Impact Analysis Of Driver And Restraints

Figure 8.           North America Doxorubicin Market– Revenue Forecast and Analysis

Figure 9.           North America Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)

Figure 10.        North America Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 11.        North America Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 12.        North America Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)

Figure 13.        North America Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 14.        North America Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 15.        North America Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 16.        North America Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        North America Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        North America Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        North America Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        North America Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 21.        North America Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        North America Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)

Figure 23.        North America Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        North America Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 25.        North America Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 26.        North America: Doxorubicin Market, By Key Country – Revenue (2022) (US$ Million)

Figure 27.        North America: Doxorubicin Market, by Country, 2022 & 2028 (%)

Figure 28.        US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)